(Q40711135)

23 September 2017

1 reference

title

Renal effects of antihypertensive medications: an overview (English)

1 reference

23 September 2017

Abbott KC

1

1 reference

23 September 2017

Bakris G

series ordinal

2

1 reference

23 September 2017

publication date

1 May 1993

1 reference

The Journal of Clinical Pharmacology

23 September 2017

published in

1 reference

23 September 2017

volume

33

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

392-399

1 reference

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

The evolution of antihypertensive therapy: an overview of four decades of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Advantages and limitations of diuretic therapy in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Diabetic nephropathy: hemodynamic basis and implications for disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Evidence for a renal alpha-adrenergic receptor inhibiting renin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

The long-term effect of propranolol therapy on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

The renal, forearm, and hormonal responses to standing in the presence and absence of propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Influence of metoprolol, alone and in combination with a thiazide diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Effect of tertatolol on glomerular hemodynamics in the normal Munich-Wistar rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Effects of calcium antagonists on deranged modulation of the renal function curve in salt-sensitive patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Effects of different calcium antagonists on proteinuria associated with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

"Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Nifedipine-induced renal dysfunction. Alterations in renal hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Intrarenal actions of converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

The role of renal hemodynamics in the antihypertensive effect of captopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Renal effects of angiotensin converting enzyme inhibitors in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Renal effects of atrial natriuretic factor during control of the renin-angiotensin system in anesthetized dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB04677.X

10.1002/J.1552-4604.1993.TB04677.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference